Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tedizolid

A second-generation oxazolidinone antibiotic, given as a phosphate prodrug by mouth or intravenously. Approved in the United States in 2014 and in Europe in 2015 for acute bacterial skin and skin structure infections, including MRSA. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It originated in South Korea and was the second antibiotic approved in the United States under the GAIN Act, the law that rewards new medicines against resistant infections.

TedizolidGo to the active ingredient →
TedizolidActive ingredientTedizolidCat. No. P-T031-001CAS 856866-72-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.